Total Payments
$922.77
2024 Payments
$270.52
Companies
10
Transactions
37
Medicare Patients
2,592
Medicare Billing
$480,757
Payment Breakdown by Category
Food & Beverage$783.82 (84.9%)
Education$138.95 (15.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $783.82 | 35 | 84.9% |
| Education | $138.95 | 2 | 15.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $298.24 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $157.89 | 5 | $0 (2024) |
| Allergan, Inc. | $113.87 | 3 | $0 (2020) |
| ABBVIE INC. | $112.18 | 5 | $0 (2024) |
| Insmed, Inc. | $56.99 | 2 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $44.12 | 2 | $0 (2023) |
| Melinta Therapeutics, LLC | $43.58 | 2 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $43.55 | 2 | $0 (2022) |
| Theravance Biopharma Inc. | $39.24 | 2 | $0 (2017) |
| ViiV Healthcare Company | $13.11 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.52 | 8 | Astellas Pharma US Inc ($113.94) |
| 2023 | $73.70 | 3 | Cumberland Pharmaceuticals, Inc. ($27.64) |
| 2022 | $89.54 | 5 | ABBVIE INC. ($38.15) |
| 2021 | $16.50 | 1 | Melinta Therapeutics, LLC ($16.50) |
| 2020 | $41.98 | 2 | Paratek Pharmaceuticals, Inc. ($21.75) |
| 2019 | $99.63 | 5 | Merck Sharp & Dohme Corporation ($39.27) |
| 2018 | $201.42 | 6 | Merck Sharp & Dohme Corporation ($107.78) |
| 2017 | $129.48 | 7 | Merck Sharp & Dohme Corporation ($74.31) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/16/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: ANTIFUNGALS | ||||||
| 12/06/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/07/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/24/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Infectious Diseases | ||||||
| 05/23/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 04/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Respiratory | ||||||
| 12/04/2023 | AbbVie Inc. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/22/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/24/2023 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 12/12/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ANTIBIOTIC | ||||||
| 07/15/2022 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 03/09/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: HIV | ||||||
| 02/23/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/16/2021 | Melinta Therapeutics, LLC | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ANTIBIOTICS | ||||||
| 06/23/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/07/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ANTIBIOTIC | ||||||
| 06/28/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/14/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Respiratory | ||||||
| 04/04/2019 | Astellas Pharma US Inc | CRESEMBA (Drug), MYCAMINE, AMBISOME | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID, ZINPLAVA | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2018 | Allergan Inc. | TEFLARO (Drug) | Education | In-kind items and services | $39.95 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 608 | 8,170 | $473,162 | $155,721 |
| 2022 | 11 | 647 | 4,928 | $354,382 | $111,266 |
| 2021 | 11 | 732 | 5,651 | $422,442 | $147,361 |
| 2020 | 8 | 605 | 996 | $180,742 | $66,408 |
Total Patients
2,592
Total Services
19,745
Medicare Billing
$480,757
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0875 | Injection, dalbavancin, 5 mg | Office | 2023 | 22 | 7,200 | $288,000 | $84,824 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 196 | 388 | $54,708 | $23,498 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 225 | $44,550 | $20,563 | 46.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 100 | 102 | $33,276 | $9,997 | 30.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 36 | 104 | $21,840 | $4,960 | 22.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $14,328 | $4,523 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 67 | $8,844 | $4,373 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $2,732 | $1,339 | 49.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $3,164 | $892.50 | 28.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 20 | $1,720 | $752.66 | 43.8% |
| J0875 | Injection, dalbavancin, 5 mg | Office | 2022 | 11 | 3,900 | $156,000 | $39,946 | 25.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 164 | 318 | $62,964 | $24,942 | 39.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 203 | 372 | $52,452 | $20,059 | 38.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 111 | 113 | $36,850 | $11,281 | 30.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 36 | 94 | $19,740 | $4,731 | 24.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $12,338 | $4,548 | 36.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 25 | 25 | $5,650 | $1,905 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 28 | $3,696 | $1,875 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $3,104 | $1,487 | 47.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 17 | $1,462 | $451.22 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $126.00 | $41.58 | 33.0% |
| J0875 | Injection, dalbavancin, 5 mg | Office | 2021 | 12 | 4,400 | $176,000 | $54,990 | 31.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 196 | 445 | $88,110 | $35,857 | 40.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 239 | 457 | $64,437 | $25,001 | 38.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 137 | 144 | $46,843 | $14,311 | 30.6% |
About Dr. Majella Angelie Steinberg, D.O
Dr. Majella Angelie Steinberg, D.O is a Internal Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437385226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Majella Angelie Steinberg, D.O has received a total of $922.77 in payments from pharmaceutical and medical device companies, with $270.52 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($783.82).
As a Medicare-enrolled provider, Steinberg has provided services to 2,592 Medicare beneficiaries, totaling 19,745 services with total Medicare billing of $480,757. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pittsburgh, PA
- Active Since 06/08/2009
- Last Updated 01/26/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437385226
Products in Payments
- DALVANCE (Drug) $186.10
- DIFICID (Drug) $174.04
- VIBATIV (Drug) $83.36
- CUBICIN RF (Drug) $74.31
- Arikayce (Drug) $56.99
- NUZYRA (Drug) $43.55
- TEFLARO (Drug) $39.95
- Cresemba (Drug) $30.87
- ZERBAXA (Drug) $29.26
- CRESEMBA (Drug) $28.02
- Rezzayo (Drug) $27.08
- NOXAFIL (Drug) $20.63
- Orbactiv (Drug) $16.50
- APRETUDE (Biological) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pittsburgh
Christopher Gisler, Md, MD
Internal Medicine — Payments: $978,960
Internal Medicine $978,960
Dr. Joshua Silverstein, M.d, M.D
Internal Medicine — Payments: $472,100
Internal Medicine $472,100
Brian Henry, Md, MD
Internal Medicine — Payments: $207,815
Internal Medicine $207,815
Meilin Young, Md, MD
Internal Medicine — Payments: $155,901
Internal Medicine $155,901
Dr. Enrico Novelli, M.d, M.D
Internal Medicine — Payments: $114,138
Internal Medicine $114,138
Bassel Sayegh, M.d, M.D
Internal Medicine — Payments: $98,056
Internal Medicine $98,056